Lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patient =18 years old, male or female; 2) Lung cancer confirmed by histological or cytological pathology; 3) The researchers confirmed meningeal metastasis in the patients through comprehensive clinical evaluation, which included symptom evaluation, imaging evaluation or cerebrospinal fluid pathology evaluation; 4) have previously received anti-tumor therapy that meets the standard of clinical practice; 5) Prior treatment with radiation or surgery targeting the central nervous system is permitted; 6) Admission of patients without or with signs or symptoms of CNS;
Exclusion criteria
Exclusion criteria: 1) Currently combined with other tumors other than NSCLC; 2) Have other malignant tumors in the last 5 years or have a history of other malignant tumors, except skin basal cell carcinoma, cervical carcinoma in situ and breast ductal carcinoma in situ which have been effectively controlled
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment regimens and prognostic factors for lung cancer with meningeal metastasis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Symptom improvement rate; | — |
Countries
China
Contacts
The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital